Corcept TherapeuticsNasdaq Capital Market: CORT: Public biopharmaceutical developing and commercializing cortisol-modulating medicines for severe endocrine, cancer, metabolic, and neurologic disorders.
2+ YOESupport IP docketing and patent prosecution, maintain patent and trademark records, coordinate deadlines with attorneys and outside counsel; USPTO e-filing experience and strong organization required.